NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EditCo Bio

EditCo Bio

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://www.editco.bio/

Last Round

VC Round

Mar 27, 2024

Company Overview

EditCo Bio is a biotechnology company that provides CRISPR-engineered cell models and high-throughput gene editing solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Freemium

AI Layer

Application

Keywords

genome engineeringengineered cell linescell line engineeringgene editingCRISPR as a serviceCRISPR servicesdrug discovery toolscell and gene therapygene knockout cellsgene knock-in cellsfunctional genomicslife science toolsCRISPR reagentssgRNA librariesiPSCsICE analysisautomated cell engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EditCo Bio Comparables

Compare EditCo Bio with similar companies based on industry and business-model similarity.

EditCo Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SIRION Biotech
79%
Synthego
77%
Applied StemCell, Inc.
76%

EditCo Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 27, 2024

Key People

Founding team and executive leadership

Edward Russell

Chief Executive Officer

Executive Team

Stephen Gunstream

Chief Executive Officer

Executive Team

EditCo Bio Investors

Notable investors and investment history

EditCo Bio investors
InvestorRounds
Telegraph Hill PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors increased 119% MoM, reaching 19.3K.

  • Nov 27, 2024

    Grew 16% QoQ, from 79 to 92 employees.

EditCo Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EditCo Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EditCo Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range77
Year Founded2024
Last FundingMar 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.